Sec. 7. (a) A research institution in Indiana may apply to the division to receive financial assistance from the fund to conduct one (1) or more clinical studies to evaluate the efficacy of psilocybin and ibogaine as an alternative treatment for mental health and other medical conditions, including the following: (1) Posttraumatic stress disorder, with a focus on treating the disorder in combat veterans and first responders. (2) Anxiety. (3) Depression. (4) Bipolar disorder. (5) Chronic pain. (6) Migraines. (7) Alcohol use disorder. (8) Tobacco use disorder. (b) In conducting a clinical study under this section, a research institution that receives a grant under this chapter shall do the following: (1) Include veterans and first responders in the study sample. (2) Evaluate and determine whether psilocybin is an effective treatment for mental health and other medical conditions described in subsection (a). (3) Compare the efficacy of psilocybin as a treatment for mental health and other medical conditions described in subsection (a) with the efficacy of other current treatment options for mental health and other medical conditions described in subsection (a). (4) Before entering the study, require each participant to undergo a mental health evaluation.
‹ Prev All Indiana sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.